The Manufacturers Life Insurance Company Boosts Stock Position in Avantor, Inc. (NYSE:AVTR)

The Manufacturers Life Insurance Company boosted its position in Avantor, Inc. (NYSE:AVTRFree Report) by 653.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 6,174,736 shares of the company’s stock after purchasing an additional 5,354,678 shares during the period. The Manufacturers Life Insurance Company’s holdings in Avantor were worth $159,740,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quadrature Capital Ltd lifted its stake in shares of Avantor by 45.3% during the first quarter. Quadrature Capital Ltd now owns 18,265 shares of the company’s stock valued at $467,000 after buying an additional 5,695 shares during the period. Kennedy Capital Management LLC lifted its stake in shares of Avantor by 50.9% during the 1st quarter. Kennedy Capital Management LLC now owns 79,483 shares of the company’s stock worth $2,032,000 after purchasing an additional 26,814 shares during the period. California State Teachers Retirement System boosted its holdings in shares of Avantor by 0.5% during the first quarter. California State Teachers Retirement System now owns 1,067,938 shares of the company’s stock worth $27,307,000 after purchasing an additional 5,230 shares during the last quarter. Tidal Investments LLC grew its position in shares of Avantor by 19.6% in the first quarter. Tidal Investments LLC now owns 14,654 shares of the company’s stock valued at $375,000 after purchasing an additional 2,399 shares during the period. Finally, Comerica Bank increased its stake in Avantor by 7.6% in the first quarter. Comerica Bank now owns 914,951 shares of the company’s stock valued at $23,395,000 after purchasing an additional 64,450 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Down 0.4 %

Shares of NYSE AVTR opened at $21.01 on Wednesday. The stock has a fifty day moving average price of $23.65 and a 200 day moving average price of $23.79. The company has a market cap of $14.30 billion, a P/E ratio of 45.67, a P/E/G ratio of 2.52 and a beta of 1.35. Avantor, Inc. has a 12-month low of $19.59 and a 12-month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of research analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Wells Fargo & Company lowered their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. UBS Group cut their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Finally, Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $27.57.

Read Our Latest Analysis on Avantor

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company’s stock.

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.